- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Transgene (TRNG)
Assess today's live Transgene (TRNG) share price, performance and insights using our live Paris: TRNG stock exchange data.
Analyse the historical data and Transgene share price performance charts on this page. Our technical summary section provides analysis on Transgene share price buy/sell indicators using real-time data (or discuss the Transgene (TRNG) stock price today with other investors in the Transgene EPA share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current EPA TRNG share price (ISIN: FR0005175080) to enhance your trading decisions with our free investment tools and resources.
What Is the Transgene Share Price Today?
The Transgene share price today is 0.950.
What Is the Stock Symbol for Transgene
The stock symbol (or 'ticker') for Transgene is "TRNG."
What Stock Exchange Does Transgene Trade On?
Transgene is listed and trades on the Paris stock exchange.
Is Transgene a Good Stock to Buy?
Determining whether Transgene—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Transgene share price performance charts on this page. Our technical summary section provides analysis on Transgene share price buy/sell indicators using real-time data (or discuss the Transgene (TRNG) stock price today with other investors in the Transgene EPA share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current EPA TRNG share price (ISIN: FR0005175080) to enhance your trading decisions with our free investment tools and resources.
What Is the Transgene Share Price Today?
The Transgene share price today is 0.950.
What Is the Stock Symbol for Transgene
The stock symbol (or 'ticker') for Transgene is "TRNG."
What Stock Exchange Does Transgene Trade On?
Transgene is listed and trades on the Paris stock exchange.
Is Transgene a Good Stock to Buy?
Determining whether Transgene—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
0.950
-0.014(-1.45%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.950
0.970
52 wk Range
0.530
1.500
TRNG is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.9500.970
52 wk Range
0.5301.500
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TRNG Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
1.850
Upside
+94.74%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Short term obligations exceed liquid assets
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Transgene Company Profile
Transgene SA, a biotechnology company, designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer in France. It involved in developing TG4050, a therapeutic vaccine that is in Phase II clinical trial for the treatment of ovarian cancer, and head and neck cancers; TG4001, a therapeutic vaccine, which is in Phase II clinical trial for the treatment of human papillomavirus (HPV 16) positive cancers; TG6002, an oncolytic virus that is in Phase I/IIa clinical trial for the treatment of solid tumors, including gastrointestinal adenocarcinoma; and BT-001, an oncolytic virus, which is in Phase I/II clinical trial for the treatment of solid tumors. The company also develops TG6050 for the treatment of non-small cell lung cancer that is in Phase 1 clinical trial; and Pexa-Vec, an oncolytic virus for the treatment of solid tumors. It has strategic collaboration agreements with AstraZeneca, Merck KGaA, Pfizer, and NEC Corporation; licensing agreements with SillaJen, Ascend BioPharmaceutical, and Valneva; and agreements with Merck & Co, Sanofi, and BioInvent. The company was incorporated in 1979 and is headquartered in Illkirch-Graffenstaden, France. Transgene SA is a subsidiary of TSGH SAS.
Compare TRNG to Peers and Sector
Metrics to compare | TRNG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTRNGPeersSector | |
|---|---|---|---|---|
P/E Ratio | −7.1x | −3.0x | −0.6x | |
PEG Ratio | 0.28 | 0.04 | 0.00 | |
Price/Book | −72.2x | 1.3x | 2.6x | |
Price / LTM Sales | 34.3x | 8.1x | 3.4x | |
Upside (Analyst Target) | 94.7% | 182.3% | 41.1% | |
Fair Value Upside | Unlock | 13.1% | 5.3% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 1.850
(+94.74% Upside)
Earnings
Latest Release
Nov 04, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Transgene (TRNG) Share Price Today?
The live Transgene share price today is 0.950
What Stock Exchange Does Transgene (TRNG) Trade On?
Transgene is listed and trades on the Paris Stock Exchange.
What Is the Ticker (Stock Symbol) for Transgene?
The stock symbol (also called a 'ticker') for Transgene is "TRNG."
What Is the Current Transgene Market Cap?
As of today, Transgene market capitalisation is 260.14M.
What Is Transgene's (TRNG) Earnings Per Share (TTM)?
The Transgene EPS is currently -0.28 (Trailing Twelve Months).
When Is the Next Transgene Earnings Date?
Transgene's next earnings report will be released on 18 Mar 2026.
Is TRNG a Buy or Sell From a Technical Analyst Perspective?
Based on today's Transgene moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Transgene Stock Split?
Transgene has split 4 times. (See the TRNG stock split history page for full effective split date and price information.)
How Many Employees Does Transgene Have?
Transgene has 147 employees.
What is the current trading status of Transgene (TRNG)?
As of 18 Jan 2026, Transgene (TRNG) is trading at a price of 0.950, with a previous close of 0.964. The stock has fluctuated within a day range of 0.950 to 0.970, while its 52-week range spans from 0.530 to 1.500.
What Is Transgene (TRNG) Price Target According to Analysts?
The average 12-month price target for Transgene is EUR1.85, with a high estimate of EUR2.6 and a low estimate of EUR1.1. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +94.74% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.